2017 Consumer Survey: Healthcare Cybersecurity and Digital Trustaccenture
Accenture’s 2017 Consumer Survey on Healthcare Cybersecurity and Digital Trust identifies consumers’ experiences with healthcare data breaches and their attitudes toward healthcare data, digital trust, roles and responsibilities, data sharing and breaches.
2017 Consumer Survey: Healthcare Cybersecurity and Digital Trustaccenture
Accenture’s 2017 Consumer Survey on Healthcare Cybersecurity and Digital Trust identifies consumers’ experiences with healthcare data breaches and their attitudes toward healthcare data, digital trust, roles and responsibilities, data sharing and breaches.
Healthcare organizations are struggling to keep up with dramatic and unpredictable industry change. Their current operations, with complex and disconnected technologies and processes, make it hard to manage costs, improve service quality, and become more consumer-centric—all of which have become top priorities.
The Accenture Life Sciences practice helps companies pivot to the patient for best outcomes. See how we can help you. Visit https://accntu.re/2l5mUGu to learn more.
With the changing A & M Industry, the CII BCG report highlights key factors and lays the path forward for the industry to achieve new growth during the rapid transformation in the digital age and time over the next decade.
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and patient care. Visit http://www.accenture.com/newscience to learn more.
Mundo gamer e a oportunidade de entrada pela abordagem do movimentoaccenture
O documento discute a relação entre jogos eletrônicos e atividades físicas, analisando o mercado de games, a evolução histórica da inclusão de movimentos nos jogos e os perfis de jogadores brasileiros. Ele apresenta mapeamentos de stakeholders no mercado de games e sua relação com jogadores, além de insights sobre hábitos de exercício e preferências de marcas entre gamers.
Comprised of four integrated solutions and underpinned by leading technology, Accenture's INTIENT Patient Platform helps life sciences companies better support patients from clinical trials through ongoing treatment and wellness. Visit https://accntu.re/2VWigzh to learn more.
An introduction to our Patient Solution that enables Healthcare and Life Sciences organizations to provide insight-driven services and patient analytics.
Reinventing the Last Mile: Win the Race to the Top (AU)accenture
A pivotal moment has arrived for traditional postal organisations. As retailers race to the top to win customer loyalty and market share, they are transforming their supply chains to enable the fast and free shipping that customers not only want, but expect. However, traditional postal organisations have not responded accordingly, and are now putting their future survival at risk. But by joining the race to the top—and taking advantage of their enviable position to offer the solutions retailers are looking for—they can transform their networks and win the last mile for decades to come.
I have framed this talk to encourage Pharmacy students to embrace computing in general, and data science and artificial intelligence techniques in particular. The reason is that data-driven science has overtaken traditional lab science; chemistry and biology that underlie pharmacy have become data-driven sciences, and a significant majority of the new jobs in pharma industries demand data analysis skills. Increasingly, traditional bioinformatics approaches are being complemented or replaced by machine learning or deep learning algorithms, especially for cases that have large data sets. I will provide a few examples (e.g., drug discovery, finding adverse drug reactions and broadly pharmacovigilance, and selecting patients for clinical trials) to demonstrate how big data and/or AI are indispensable to pharma research and industry today.
Análise de Cases do Itaú para a disciplina de Campanhas Publicitárias, ministrada pelo prof. Victor Mazzei.
Tie-in | Itaú no programa encontro com Fátima Bernardes
Celebridade Endossante | Itaú racha com você - Luciano Huck
Transmídia Storytelling | Bebê sem papel
Mondi Europe & International Corporate Presentation - Status February 2012Mondi Group
Mondi is an international paper and packaging company, with production operations across 31 countries and revenues of €5.3 billion in 2009. The Group’s key operations are located in Central Europe, Russia and South Africa and employed 31,000 people on average in 2009.
Mondi is fully integrated across the paper and packaging process, from the growing of wood and the manufacture of pulp and paper (including recycled paper), to the conversion of packaging papers into corrugated packaging and industrial bags.
The Group is principally involved in the manufacture of uncoated fine paper (UFP), packaging paper and converted packaging products, as well as speciality products.
Mondi is a dual listed company, with primary listings on the Johannesburg and London stock exchanges under the ticker codes MND (JSE) and MNDI (LSE) respectively. The Group has been recognised for its sustainability performance through its inclusion in the FTSE4Good UK, Europe and Global indices in 2008 and 2009 and the JSE’s Socially Responsible Investment (SRI) Index in 2007, 2008 and 2009.
Healthcare organizations are struggling to keep up with dramatic and unpredictable industry change. Their current operations, with complex and disconnected technologies and processes, make it hard to manage costs, improve service quality, and become more consumer-centric—all of which have become top priorities.
The Accenture Life Sciences practice helps companies pivot to the patient for best outcomes. See how we can help you. Visit https://accntu.re/2l5mUGu to learn more.
With the changing A & M Industry, the CII BCG report highlights key factors and lays the path forward for the industry to achieve new growth during the rapid transformation in the digital age and time over the next decade.
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and patient care. Visit http://www.accenture.com/newscience to learn more.
Mundo gamer e a oportunidade de entrada pela abordagem do movimentoaccenture
O documento discute a relação entre jogos eletrônicos e atividades físicas, analisando o mercado de games, a evolução histórica da inclusão de movimentos nos jogos e os perfis de jogadores brasileiros. Ele apresenta mapeamentos de stakeholders no mercado de games e sua relação com jogadores, além de insights sobre hábitos de exercício e preferências de marcas entre gamers.
Comprised of four integrated solutions and underpinned by leading technology, Accenture's INTIENT Patient Platform helps life sciences companies better support patients from clinical trials through ongoing treatment and wellness. Visit https://accntu.re/2VWigzh to learn more.
An introduction to our Patient Solution that enables Healthcare and Life Sciences organizations to provide insight-driven services and patient analytics.
Reinventing the Last Mile: Win the Race to the Top (AU)accenture
A pivotal moment has arrived for traditional postal organisations. As retailers race to the top to win customer loyalty and market share, they are transforming their supply chains to enable the fast and free shipping that customers not only want, but expect. However, traditional postal organisations have not responded accordingly, and are now putting their future survival at risk. But by joining the race to the top—and taking advantage of their enviable position to offer the solutions retailers are looking for—they can transform their networks and win the last mile for decades to come.
I have framed this talk to encourage Pharmacy students to embrace computing in general, and data science and artificial intelligence techniques in particular. The reason is that data-driven science has overtaken traditional lab science; chemistry and biology that underlie pharmacy have become data-driven sciences, and a significant majority of the new jobs in pharma industries demand data analysis skills. Increasingly, traditional bioinformatics approaches are being complemented or replaced by machine learning or deep learning algorithms, especially for cases that have large data sets. I will provide a few examples (e.g., drug discovery, finding adverse drug reactions and broadly pharmacovigilance, and selecting patients for clinical trials) to demonstrate how big data and/or AI are indispensable to pharma research and industry today.
Análise de Cases do Itaú para a disciplina de Campanhas Publicitárias, ministrada pelo prof. Victor Mazzei.
Tie-in | Itaú no programa encontro com Fátima Bernardes
Celebridade Endossante | Itaú racha com você - Luciano Huck
Transmídia Storytelling | Bebê sem papel
Mondi Europe & International Corporate Presentation - Status February 2012Mondi Group
Mondi is an international paper and packaging company, with production operations across 31 countries and revenues of €5.3 billion in 2009. The Group’s key operations are located in Central Europe, Russia and South Africa and employed 31,000 people on average in 2009.
Mondi is fully integrated across the paper and packaging process, from the growing of wood and the manufacture of pulp and paper (including recycled paper), to the conversion of packaging papers into corrugated packaging and industrial bags.
The Group is principally involved in the manufacture of uncoated fine paper (UFP), packaging paper and converted packaging products, as well as speciality products.
Mondi is a dual listed company, with primary listings on the Johannesburg and London stock exchanges under the ticker codes MND (JSE) and MNDI (LSE) respectively. The Group has been recognised for its sustainability performance through its inclusion in the FTSE4Good UK, Europe and Global indices in 2008 and 2009 and the JSE’s Socially Responsible Investment (SRI) Index in 2007, 2008 and 2009.